Carnegie Mellon develops edible medical devices; NinePoint wins expanded FDA nod;

@FierceMedDev: FDA wants more data on Insuline's pump. Article | Follow @FierceMedDev

@MarkHFierce: Now this is just cool: Carnegie Mellon U. folks are developing med devices you would swallow and partially digest. More | Follow @MarkHFierce

 @DamianFierce: A spike in restructuring costs slashed Covidien's profits, despite a revenue jump. Story | Follow @DamianFierce

> The number of female angel investors grew in 2012, according to the Center for Venture Research at the University of New Hampshire. Story

> Carnegie Mellon University researchers are developing tiny electronic medical devices that a patient could swallow and partially digest after treatment is delivered. Story

> 2012 Fierce 15 winner Orthocare Innovations won a gold Edison Award for its Magellan foot and ankle device. More

> The European Society of Cardiology is urging physicians to take care when selecting patients for renal denervation, making sure their anatomy can handle the procedure. Article

> Deep brain stimulation device implants helped obese mice reduce their appetites, a new study by researchers at the University of Pennsylvania Perelman School of Medicine and elsewhere concludes. Story

> NinePoint Medical, another 2012 Fierce 15 winner, won an additional 510(k) clearance for its NvisionVLE imaging system, allowing it to be used to image esophageal microstructure. Release

> The FDA wants to regulate the use of internationally recognized symbols for medical device and biologic product labeling. Item

Biotech News

@FierceBiotech: NIH stops HIV vaccine trial after immunizations fail. Story | Follow @FierceBiotech

@JohnCFierce: So EU doesn't like Pfizer's Xeljanz at all. That's a blow. More | Follow @JohnCFierce

@RyanMFierce: Industry Voices: Time to Take Fecal Transplantation Seriously. Article | Follow @RyanMFierce

> Biotech startup hustles new Alzheimer's program to the clinic. News

> Johnson & Johnson, Evotec bask in Harvard's breaking diabetes discovery. Article

> Biotech Receptos trots out terms for $71M IPO. Item

> Theravance to split into two biotech groups as GSK drugs progress. More

Pharma News

@FiercePharma: Trending at FiercePharma.com: European regulators tag 100-plus drugs with 'black triangle. Article | Follow @FiercePharma

@EricPFierce: Ipsen warns of shortages of its orphan drug Increlex. Story | Follow @EricPFierce

> Docs call drugmakers 'profiteers' for costs of cancer meds. Story

> Pfizer appealing CHMP ruling on RA treatment Xeljanz. Report

> Humira carries AbbVie in its first quarter as standalone company. More

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.